AKI D Inpatient Problem Outpatient Solution. Jeff Giullian, MD MBA Renal Physicians Association Annual Meeting March 2017

Size: px
Start display at page:

Download "AKI D Inpatient Problem Outpatient Solution. Jeff Giullian, MD MBA Renal Physicians Association Annual Meeting March 2017"

Transcription

1 AKI D Inpatient Problem Outpatient Solution Jeff Giullian, MD MBA Renal Physicians Association Annual Meeting March 2017

2 Today s Agenda Historical Background Epidemiology Rules and Regulations Dollars and Sense What lay ahead? Best Practices

3 Timeline Trade Bill CMS stops paying directly for AKI dialysis facilities CMS stops paying for non ESRD care at dialysis facilities CMS will cover AKI at dialysis facilities 2003 OPPS Pays for non routine ESRD (hospital outpatient) US Nat l ESRD Program

4 Today s Agenda Historical Background Epidemiology Rules and Regulations Dollars and Sense What lay ahead? Best Practices

5 Broadly, 2 types of patients: Prior known CKD (approximately 1/8) Prior unknown or non CKD Acute Tubular Necrosis Leading Cause 45% of all AKI, 70% of ICU Sepsis/Hypotension/Reduced renal perfusion Drugs/Nephrotoxins Severe volume depletion AKI Etiologies (In General)

6 Figure 5.3 Unadjusted rates of first hospitalization with AKI, per 1,000 patient years at risk, by age and year, (b) Clinformatics (aged 22+) AKI: Overview KDIGO: Abrupt decrease in kidney function over 7 days or less per million population 7 18% (or 20%) of hospitalized 50% of ICU 2 million deaths annually Data Source: Special analyses, Medicare 5% sample and Clinformatics. (a) Age as of January 1 of specified year. All patient years at risk for Medicare patients aged 66 and older who had both Medicare Parts A & B, no Medicare Advantage plan, no ESRD by first service date from Medical Evidence form, and were alive on January 1 of year shown. Censored at death, ESRD, end of Medicare Part A & B participation, or switch to Medicare Advantage program. (b) All patient years at risk for Clinformatics commercial insurance patients aged 22 and older who were enrolled in the plan, did not have diagnoses of ESRD, and were alive on January of year shown. Abbreviation: AKI, acute kidney injury; ESRD, end stage renal disease Annual Data Report, Vol 1, CKD, Ch 5 6

7 Clinical Nuances Wide variability in the incidence and rate of recovery of renal function. No guidelines to determine how or when an AKI D patient has transitioned to ESRD. No evidence exists that ESRD clinical practice guidelines (i.e., anemia management, MBD) are applicable to AKI patients. Loose definition of AKI may impact how nephs will categorize patients going forward Jorge Cerdá et al. CJASN 2008;3: by American Society of Nephrology

8 AKI D Doubling Hsu, RK et al Temporal changes in incidence of dialysis requiring AKI JASN ; 2013

9 Acute Kidney Injury Dialysis Incidence 2015 DaVita HealthCare Partners Inc. All rights reserved. Proprietary and confidential. For internal use only. Brown, JR et al Am. J Nephrology Aug 2016

10 Discharges: AKI vs No AKI AKI No AKI Medicare Discharges, USRDS 2014

11 Discharges: AKI vs No AKI AKI Fewer Home Discharges More Death No AKI Medicare Discharges, USRDS 2014

12 Dialysis Location Advantage Disadvantage Inpatient Hospital based unit Continuity of Care Convenience Acute care setting Status quo LOS, Cost, Complications, Capacity Capacity & limited availability Admissions requirement Cost LTAC or Rehab Outpatient ESRD Center Convenience Ancillary services Cost Location Heung, M et al CJSAN 10: Must qualify Cost Lack of AKI specific protocols Pressure for discharge Fewer ancillary services Fewer physician visits

13 More Epidemiology 170,000+ AKI D patients annually 4 5% of all ICU patients require dialysis ICU census growing, currently over 5 million admissions Mortality declining 5 20% dialysis dependent at discharge Other references: 10 30% Cost $10 Billion/year 2015 DaVita HealthCare Partners Inc. All rights reserved. Proprietary and confidential. For internal use only.

14 Figure 5.1 Percent of Medicare patients aged 66+ (a) with at least one AKI hospitalization, and (b) percent among those with an AKI hospitalization that required dialysis, by year, (b) Percent of patients requiring dialysis among those with a first AKI hospitalization Data Source: Special analyses, Medicare 5% sample. (a) Percent with an AKI hospitalization among all Medicare patients aged 66 and older who had both Medicare Parts A & B, no Medicare Advantage plan, no ESRD by first service date from Medical Evidence form, and were alive on January 1 of year shown. (b) Percent of patients receiving dialysis during their first AKI hospitalization among patients with a first AKI hospitalization. Dialysis is identified by a diagnosis or charge for dialysis on the AKI hospitalization inpatient claim or a physician/supplier (Part B) claim for dialysis during the time period of the AKI inpatient claim. Abbreviations: AKI, acute kidney injury; ESRD, end stage renal disease Annual Data Report, Vol 1, CKD, Ch 5 14

15 Epidemiology of AKI 20% of hospitalized patients develop AKI. Most recover before the need for dialysis, but 1 2% of total patients require dialysis. Of individuals with AKI D: ~50% will die in the hospital ~25% will recover renal function ~25% (10 30%) will require dialysis upon hospital discharge Some will be deemed ESRD Others may still regain renal fxn eventually (Cerda et al. CJASN 2015).

16 Medicare: 1 year after AKI (Death Censored) Data Source: Special analyses, Medicare 5% sample. Medicare patients aged 66 and older who had both Medicare Parts A & B, no Medicare Advantage plan, did not have ESRD, were discharged alive from a first AKI hospitalization in 2012 or 2013, and did not have any claims with a diagnosis of CKD in the 365 days prior to the AKI. Renal status after AKI determined from claims between discharge from AKI hospitalization and 365 days after discharge. Stage determined by 585.x claim closest to 365 days after discharge; ESRD by first service date on Medical Evidence form. Abbreviations: AKI, acute kidney injury; CKD, chronic kidney disease; ESRD, end stage renal disease Annual Data Report, Vol 1, CKD, Ch 5 16

17 (Cerda et al. CJASN 2015). In Hospital AKI

18 Chawla, LS et al Nature Reviews: Nephrology 2017 epub Feb 2017 AKD: New term coined to address the grey zone between AKI and CKD/ESRD

19 St. Elsewhere Community 200 Bed Hospital 2,000 AKI

20 Today s Agenda Historical Background Epidemiology Rules and Regulations Dollars and Sense What lay ahead? Best Practices

21 SSA Amendment (TPA/TAA) Dialysis services furnished on or after January 1, 2017, by a renal dialysis facility to an individual with acute kidney injury. (paraphrase) In the case of renal dialysis services to an individual with AKI, the payment shall be the base rate for ESRD services Applicable geographic adjustment m May be adjusted by the Secretary on a budget neutral basis. (paraphrase) No limitation on treatments monthly

22 AKI: Definition For payment, the term Acute Kidney Injury refers to: an individual who has acute loss of renal function and does not receive renal dialysis services for ESRD.

23 Payment to hospital based and freestanding ESRD facilities. PPS base rate adjusted by the wage index/geography No separate payment for typical renal services Dialysis drugs EPO/ Biologic Renal labs Supplies No $0.50 to the Network CMS Rules

24 Limitations? Isolated UF: Peritoneal dialysis Home HD: NOT reimbursed! There are no billing limits for treatments during a monthly billing cycle. However, there will only be payment for one treatment per day across settings; except in the instance of uncompleted treatments. No explicit limitations to seeing patient in office (E/M billing)

25 Today s Agenda Historical Background Epidemiology Rules and Regulations Dollars and Sense What lay ahead? Best Practices

26 Eyeballs-on-Your-Site.jpg Doc Payments Used to report inpatient hemodialysis or outpatient hemodialysis performed on non ESRD patients $73 $ Visits during same session $107 $118 G codes TBD Feds will be watching Picture of Eye Balls Give info on RVU,e tc

27 90935 Medicare Administrative Contractor (MAC) site of service exclusion preventing use of CPT code for AKI services provided in the dialysis facility has been removed. Nephrology practices should be prepared to appeal possible denials for outpatient AKI services billed with CPT code until the guidance is formalized.

28 JV Implications: Beneficial? Extra patients AKI patients/facility 25% 35% of facilities Could account for 2% of patient population Potentially fewer drugs More labs Same amount of supplies Similar IDT workload No network costs No additional fixed costs Could a JV make a few $1,000 extra margin per year? Feasible, but mostly just beneficial to patients/hospitals

29 Cohorts Patient Cohorts Description Outpatient Hospital LTAC Low Comorbid D/c sooner Likely to recovery Low impact Fewer ESRD Reduce LOS Fewer admissions High Comorbid Require higher level of care (i.e, wound, antibiotics) Unlikely unless home health No impact to LOS Minimal impact on admissions, could reduce LOS Prolonged Hospitalization Currently considered ESRD May now label AKI Fewer 2728 on day 1 No impact to LOS No impact Extended Criteria Patients could come directly from outpatient world Wild card Close Fed monitoring? Unclear impact Fewer Hosp admissions? No impact

30 Extended Criteria AKI Will we begin to see new cohorts of patients? CHF with CKD, HRS, Chemo CKD with temporary AKI Will patients bypass the hospital? Unlike a SNF, no mandate for 3 hospital days Could use on short term basis Will we see broader use of nephrotoxic agents?

31 Abuse Appropriate Inappropriate utilization Push the envelope with IV contrast, chemo, etc Dialysis for ultrafiltration Reduce hospitalizations Reduce LTAC Allow for broader use of therapies

32 Today s Agenda Historical Background Epidemiology Rules and Regulations Dollars and Sense What lay ahead? Best Practices

33 LDO Data: AKI Treatment Average Age: 61 Average time to 2728: 51 days

34 AKI D Outpatient Treatments Rising

35 Lab Draws: LDO Data

36 Complications High likelihood of readmission Hospitals will need to understand this Docs and patients will need to accept this Does not count against SHR for Publically Reported Data (5 Star) Mortality These patients remain unstable Will not count against SMR for Publically Reported Data (5 Star)

37 Recurrent AKI Hospitalization 2016 Annual Data Report, Vol 1, CKD, Ch 5 37

38 Death and/or ESRD following AKI: Medicare 2016 Annual Data Report, Vol 1, CKD, Ch 5 38

39 Avoidable Consequences? New cohorts of AKI patietns? Dialysis beyond renal recovery Requires pre emptive vigilance Transition to ESRD without proper access/education Requires pre emptive vigilance Could be system gaming risk Joint effort from MD, IDT and family Likely will require more frequent rounding by MD

40 Today s Agenda Historical Background Epidemiology Rules and Regulations Dollars and Sense What lay ahead? Best Practices

41 Consensus Guidelines (opinion based) Recovery from RRT: Sustained independence x 14 days Renal labs 72 hours (and not more than 7 days) following last RRT Interval for subsequent evaluations based upon clinical judgment For AKI D patients in outpatient setting: Weekly assessment of pre dialysis creatinine Regular assessment of 24 hour urine collection for volume and creat/urea cl. Personalized approach that maximizes likelihood of recovery Avoidance of excessive fluid removal Chawla, LS ADQI Consensus Report. Nature Reviews: Nephrology Feb 2017

42 Best Practices Active Monitoring recommended Weekly BUN & Creatinine (pre HD) Urine output measurement and Intradialytic weight gain (record like VS) egfr monitoring by Medical Director Unknown optimal frequency of physician rounding Target Weight (Less Aggressive) Hypotension risk for second ischemic insult Bioimpedance in the future? Stop Dialysis outright vs taper or wean? Anemia management, MBD mgt?

43 Predictors of Survival Pre hospital BUN & creatinine Higher might be better Age Hospital LOS Malignancy UOP Overall recovery status at discharge. At 90 days

44 Knowledge Gaps Can we affect 90 day mortality? What % renal recovery should we expect? When is it time to call ESRD? When is it time to educate? When is it time to place access? What is the right cadence for lab monitoring? Blood: BUN/Creat, Kt/V, Minerals Urine studies: 24 hour Creatinine/urea clearance Urine output measurements

45 More Knowledge Gaps Cutoff of time before ESRD? Minimum vs Maximum? 6 12 weeks seems fair (from 1 st dialysis, from entering DaVita?) Should prior GFR/CKD status matter? Should we have a tiered protocol for access planning? When do we start Kidney Smart or Modality discussions? When deemed ESRD, does 90 day timer start? Access education and plan prior to 2728? Publically reported data: QIP & 5 Star

46 What Metrics, When? Patient volumes CMS will be watching closely Etiology Does this impact recovery prediction? Co morbidities Higher risk of death and readmission Recovery time Fair to compare docs? Mortality rates Same question? Can we standardize? Re hospitalization rates Ditto Other?

47 Standing Orders? Standardization might reduce variation in treatment Weekly/biweekly lab panel with regular reports to doc 24 hr Urine Urea/Creatinine Clearance every two weeks Monitor creatinine, consider algorithm for holding HD Phos, PTH, Albumin??? What is the utility? Facility s Governing Body most likely reviewed and made a decision regarding their use.

48 Standing Orders? Standardization might reduce variation in treatment Weekly/biweekly lab panel with regular reports to doc 24 hr Urine Urea/Creatinine Clearance every two weeks Monitor Δ creatinine, consider algorithm for holding HD Phos, PTH, Albumin??? What is the utility? Work with facility Governing Body

Chapter 5: Acute Kidney Injury

Chapter 5: Acute Kidney Injury Chapter 5: Acute Kidney Injury Introduction In recent years, acute kidney injury (AKI) has gained increasing recognition as a major risk factor for the development of chronic kidney disease (CKD). The

More information

Chapter 5: Acute Kidney Injury

Chapter 5: Acute Kidney Injury Chapter 5: Acute Kidney Injury In 2015, 4.3% of Medicare fee-for-service beneficiaries experienced a hospitalization complicated by Acute Kidney Injury (AKI); this appears to have plateaued since 2011

More information

Acute Kidney Injury Care in the Chronic Unit

Acute Kidney Injury Care in the Chronic Unit Acute Kidney Injury Care in the Chronic Unit BONNIE B GREENSPAN WITH ASSIST FROM: DENISE MURCEK, JINA BOGLE, MARY SCHIRA, OCTOBER 5, 2017 Objectives At the completion of the session, engaged participants

More information

Acute Kidney Injury. Elaine Go, RN, MSN, CNN-NP. Clinical Educator, St. Joseph Hospital Renal Center Nurse Practitioner NSMG Orange, Ca

Acute Kidney Injury. Elaine Go, RN, MSN, CNN-NP. Clinical Educator, St. Joseph Hospital Renal Center Nurse Practitioner NSMG Orange, Ca Acute Kidney Injury Elaine Go, RN, MSN, CNN-NP Clinical Educator, St. Joseph Hospital Renal Center Nurse Practitioner NSMG Orange, Ca Objectives Causes and etiologies of Acute Kidney Injury (AKI) Care

More information

REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange

REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange Agenda History of the Medicare ESRD Program Cost of Care for ESRD Patients

More information

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease

More information

2013 Bundled Payments / QIP Presented by John Greenacre

2013 Bundled Payments / QIP Presented by John Greenacre 2013 Bundled Payments / QIP 2013-2015 Presented by John Greenacre Objectives List at least 3 of the 2013 Proposed ESRD PPS regulations Review the 2013 and 2014 Final QIP changes Review 2015 and future

More information

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,

More information

Chapter 2: Identification and Care of Patients with CKD

Chapter 2: Identification and Care of Patients with CKD Chapter 2: Identification and Care of Patients with CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease

More information

Applying clinical guidelines treating and managing CKD

Applying clinical guidelines treating and managing CKD Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012

More information

Chapter 10: Dialysis Providers

Chapter 10: Dialysis Providers Chapter 10: Dialysis Providers In 2014 the two largest dialysis organizations, Fresenius and DaVita, collectively treated 69% of patients in 65% of all dialysis units (Figure 10.2). Nearly 90% of all dialysis

More information

CKD in the United States: An Overview of the USRDS Annual Data Report, Volume 1

CKD in the United States: An Overview of the USRDS Annual Data Report, Volume 1 CKD in the United States: An Overview of the USRDS Annual Data Report, Volume 1 Introduction Chronic kidney disease (CKD) has received significant attention over the last decade, primarily since the consensus

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 10: Dialysis Providers In 2013, collectively the three large dialysis organizations treated 71% of patients in 67% of all dialysis units. In the Small Dialysis

More information

Status of the CKD and ESRD treatment: Growth, Care, Disparities

Status of the CKD and ESRD treatment: Growth, Care, Disparities Status of the CKD and ESRD treatment: Growth, Care, Disparities United States Renal Data System Coordinating Center An J. Collins, MD FACP Director USRDS Coordinating Center Robert Foley, MB Co-investigator

More information

The Link Between Acute and Chronic Kidney Disease. John Arthur, MD, PhD

The Link Between Acute and Chronic Kidney Disease. John Arthur, MD, PhD The Link Between Acute and Chronic Kidney Disease John Arthur, MD, PhD Conventional Dogma Conventional dogma was that if a patient survived and recovered from AKI, he was unlikely to have long-term sequela.

More information

AKI: definitions, detection & pitfalls. Jon Murray

AKI: definitions, detection & pitfalls. Jon Murray AKI: definitions, detection & pitfalls Jon Murray Previous conventional definition Acute renal failure (ARF) An abrupt and sustained decline in renal excretory function due to a reduction in glomerular

More information

Jai R adhakrishnan, Radhakrishnan, MD Columbia University

Jai R adhakrishnan, Radhakrishnan, MD Columbia University Jai Radhakrishnan, MD Jai Radhakrishnan, MD Columbia University 1. The Patient-Centered Medical Home 2. CKD Clinic as the paradigm for PCMH? 3. Outcome data 4. The Columbia model 5. Limitations 6. Financial

More information

Chapter 6: Healthcare Expenditures for Persons with CKD

Chapter 6: Healthcare Expenditures for Persons with CKD Chapter 6: Healthcare Expenditures for Persons with CKD In this 2017 Annual Data Report (ADR), we introduce information from the Optum Clinformatics DataMart for persons with Medicare Advantage and commercial

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in ESRD patients, with atherosclerotic heart disease and congestive heart

More information

ESRD Analytical Methods Contents

ESRD Analytical Methods Contents ESRD Analytical Methods Contents Volume 2: ESRD Analytical Methods... 227 Introduction... 230 Data Sources... 230 Consolidated Renal Operations in a Web-enabled Network... 230 CMS Medicare Enrollment Database...

More information

Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale

Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale Rationale for renal replacement therapy in ICU: indications, approaches and outcomes Richard Beale RIFLE classification (ADQI group) 2004 Outcome AKIN classification Definition: Abrupt (within 48 hrs)

More information

Quarterly Dialysis Facility Compare - Preview for April 2018 Report DFC Dialysis Facility State: XX Network: 99 CCN: SAMPLE

Quarterly Dialysis Facility Compare - Preview for April 2018 Report DFC Dialysis Facility State: XX Network: 99 CCN: SAMPLE Quarterly Dialysis Facility Compare -- Preview for April 2018 Report This Quarterly DFC Preview Report includes data specific to CCN(s): 999999 Purpose of the Report This report provides you with advance

More information

Reducing Hospital Utilization and Improving Coordination of Care. July 24, 2017

Reducing Hospital Utilization and Improving Coordination of Care. July 24, 2017 Reducing Hospital Utilization and Improving Coordination of Care July 24, 2017 From 18% to 5% Rainier View Dialysis Infection Control CVC removal Hospitalization Reduction Project Wendy Lester RN, MSN,

More information

FULFILLMENT OF K/DOQI GUIDELINES 92 anemia treatment dialysis therapy vascular access

FULFILLMENT OF K/DOQI GUIDELINES 92 anemia treatment dialysis therapy vascular access INTRODUCTION ANEMIA TREATMENT hemoglobin levels epo treatment iron treatment FULFILLMENT OF K/DOQI GUIDELINES 2 anemia treatment dialysis therapy vascular access EPO DOSING PATTERNS 4 epo dosing per kg

More information

Two: Chronic kidney disease identified in the claims data. Chapter

Two: Chronic kidney disease identified in the claims data. Chapter Two: Chronic kidney disease identified in the claims data Though leaves are many, the root is one; Through all the lying days of my youth swayed my leaves and flowers in the sun; Now may wither into the

More information

Las dos caras de la cretinina sérica The two sides of serum creatinine

Las dos caras de la cretinina sérica The two sides of serum creatinine Las dos caras de la cretinina sérica The two sides of serum creatinine ASOCIACION COSTARRICENSE DE MEDICINA INTERNA San José, Costa Rica June 2017 Kianoush B. Kashani, MD, MSc, FASN, FCCP 2013 MFMER 3322132-1

More information

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1 Chapter 1 Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process This guide follows the steps of the Nutrition Care Process (NCP) nutrition assessment, nutrition diagnosis, nutrition

More information

Adding Insult to Injury. Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London

Adding Insult to Injury. Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London Acute Kidney Injury Adding Insult to Injury Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London Content 1. Brief review of AKI and its impact 2. Comments on the

More information

PD In Acute Kidney Injury. February 7 th -9 th, 2013

PD In Acute Kidney Injury. February 7 th -9 th, 2013 PD In Acute Kidney Injury February 7 th -9 th, 2013 Objectives PD as a viable initial therapy PD in AKI PD versus dhd PD versus CVVHD Why not PD first PD for AKI Early days (1970 s) PD was the option of

More information

Introduction to Volume 2: ESRD in the United States

Introduction to Volume 2: ESRD in the United States Introduction to Volume 2: ESRD in the United States Introduction Volume 2 of the USRDS Annual Data Report (ADR) offers a detailed descriptive epidemiology of end-stage renal disease (ESRD) in the United

More information

Chapter 3: Morbidity and Mortality in Patients with CKD

Chapter 3: Morbidity and Mortality in Patients with CKD Chapter 3: Morbidity and Mortality in Patients with CKD In this 2017 Annual Data Report (ADR) we introduce analysis of a new dataset. To provide a more comprehensive examination of morbidity patterns,

More information

State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE

State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE Dear State Surveyor: State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE This report is designed to provide a comparative summary of treatment patterns and patient outcomes for

More information

Plenary presentations 1

Plenary presentations 1 Wessex Cardiovascular Strategic Clinical Network Acute Kidney Injury Launch Event Wednesday 15 April 2015, 10.00 16.30 Plenary presentations 1 Wessex Acute Kidney Injury Clinical Forum Dr Mark Uniacke

More information

Caring for the AKI Survivor: What is Required?

Caring for the AKI Survivor: What is Required? Caring for the AKI Survivor: What is Required? Ron Wald, MDCM MPH FRCPC Division of Nephrology St. Michael s Hospital and University of Toronto February 28, 2019 A patient in your ICU 65M with DM, HTN,

More information

Section K. Economic costs of ESRD. Vol 3 esrd. pg 731. K tables

Section K. Economic costs of ESRD. Vol 3 esrd. pg 731. K tables Section K Economic costs of ESRD Vol 3 esrd pg 731 Table K.1 733 Total costs ($) of reported ESRD per calendar year all ESRD with at least one claim, & Table K.2 734 Total costs ($) of reported ESRD :

More information

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD Karen Solcher, MSN, APRN, NP-C, CNN-NP Nephrology Nurse Practitioner Stormont-Vail Health DISCLAIMER Adult population Clinical practice

More information

FOUR. Clinical Indicators of Care

FOUR. Clinical Indicators of Care Clinical Indicators of Care T FOUR The great questions of the time are not decided by speeches and majority decisions but by iron and blood. Otto von Bismarck, Speech to the Prussian Diet 78 ž 2000 ATLAS

More information

Future Direction of Anemia Management in ESRD. Jay B. Wish, MD 2008 Nephrology Update March 20, 2008

Future Direction of Anemia Management in ESRD. Jay B. Wish, MD 2008 Nephrology Update March 20, 2008 Future Direction of Anemia Management in ESRD Jay B. Wish, MD 2008 Nephrology Update March 20, 2008 The Evidence Normal Hct Study and CHOIR demonstrate adverse outcomes in ESA patients with target Hgb

More information

Chapter Five Clinical indicators & preventive health

Chapter Five Clinical indicators & preventive health Chapter Five Clinical indicators & preventive health The painter who draws merely by practice and by eye, without any reason, is like a mirror which copies every thing placed in front of it without being

More information

Clinical Performance Goals

Clinical Performance Goals Clinical Performance Goals 2011-2012 Clinical Performance Goals 2011-2012 Table of Contents Table of Contents... 1 Health Care Quality Improvement Program... 2 Clinical Performance Measures... 6 Chapter

More information

TELENEPHROLOGY: EXPERIENCE CARING FOR HOSPITALIZED PATIENTS IN A RURAL COMMUNITY HOSPITAL (1,978 VISITS OVER 2 YEARS)

TELENEPHROLOGY: EXPERIENCE CARING FOR HOSPITALIZED PATIENTS IN A RURAL COMMUNITY HOSPITAL (1,978 VISITS OVER 2 YEARS) TELENEPHROLOGY: EXPERIENCE CARING FOR HOSPITALIZED PATIENTS IN A RURAL COMMUNITY HOSPITAL (1,978 VISITS OVER 2 YEARS) Using Telemedicine for the care of Renal Patients (ESRD and CKD) at a Rural Regional

More information

Clinical Performance Measures for ESRD Patients. Lana Kacherova, QI Director, ESRD Network th Annual NANT Symposium February 12, 2009

Clinical Performance Measures for ESRD Patients. Lana Kacherova, QI Director, ESRD Network th Annual NANT Symposium February 12, 2009 Clinical Performance Measures for ESRD Patients Lana Kacherova, QI Director, ESRD Network 18 26 th Annual NANT Symposium February 12, 2009 Health Care Quality Improvement Program (HCQIP) The Center for

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 6: Medicare Expenditures for Persons With CKD Medicare spending for patients with CKD aged 65 and older exceeded $50 billion in 2013, representing 20% of all

More information

Nephrotoxic Burden and Consequences Associated with Drug Induced AKI (D-AKI)

Nephrotoxic Burden and Consequences Associated with Drug Induced AKI (D-AKI) Nephrotoxic Burden and Consequences Associated with Drug Induced AKI (D-AKI) Sandra Kane-Gill, PharmD, MSc, FCCM, FCCP Associate Professor, University of Pittsburgh Critical Care Medication Safety Pharmacist,

More information

NATIONAL QUALITY FORUM Renal EM Submitted Measures

NATIONAL QUALITY FORUM Renal EM Submitted Measures NATIONAL QUALITY FORUM Renal EM Submitted Measures Measure ID/ Title Measure Description Measure Steward Topic Area #1662 Percentage of patients aged 18 years and older with a diagnosis of CKD ACE/ARB

More information

NoCVA Preventing Avoidable Readmissions Collaborative. Pre-work: Assessing Risk April 21, 2014

NoCVA Preventing Avoidable Readmissions Collaborative. Pre-work: Assessing Risk April 21, 2014 NoCVA Preventing Avoidable Readmissions Collaborative Pre-work: Assessing Risk April 21, 2014 Agenda Context Collaborative Overview Setting up to succeed Why assess risk of readmission Methods to assess

More information

COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS

COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS Community Oncology Alliance 2 Physician Ratings Consumers want information about quality Have become used to

More information

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC B. LCD ID Number: L34834 Status: A-Approved

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC B. LCD ID Number: L34834 Status: A-Approved LCD for Blood Glucose Monitoring in a Skilled Nursing Facility (SNF) (L34834) Contractor Name: Novitas Solutions, Inc. Contractor Number: 12502 Contractor Type: MAC B LCD ID Number: L34834 Status: A-Approved

More information

Chapter 3: Morbidity and Mortality

Chapter 3: Morbidity and Mortality Chapter 3: Morbidity and Mortality Introduction In this chapter we evaluate the morbidity and mortality of chronic kidney disease (CKD) patients continuously enrolled in Medicare. Each year s analysis

More information

ENDPOINTS FOR AKI STUDIES

ENDPOINTS FOR AKI STUDIES ENDPOINTS FOR AKI STUDIES Raymond Vanholder, University Hospital, Ghent, Belgium SUMMARY! AKI as an endpoint! Endpoints for studies in AKI 2 AKI AS AN ENDPOINT BEFORE RIFLE THE LIST OF DEFINITIONS WAS

More information

patient characteriuics Chapter Two introduction 58 increasing complexity of the patient population 60 epo use & anemia in the pre-esrd period 62

patient characteriuics Chapter Two introduction 58 increasing complexity of the patient population 60 epo use & anemia in the pre-esrd period 62 introduction 58 < increasing complexity of the patient population 6 < epo use & anemia in the pre-esrd period 62 < biochemical & physical characteristics at initiation 64 < estimated gfr at intiation &

More information

morbidity & mortality

morbidity & mortality morbidity & mortality esrd introduction of ESRD treatment. We examine these concerns throughout the ADR, particularly in Chapter One. This year we focus on infectious complications, especially those related

More information

Timing, Dosing and Selecting of modality of RRT for AKI - the ERBP position statement

Timing, Dosing and Selecting of modality of RRT for AKI - the ERBP position statement Timing, Dosing and Selecting of modality of RRT for AKI - the ERBP position statement Prof. Dr. Achim Jörres Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum

More information

Department of Nephrology

Department of Nephrology OUTCOMES DIVISION OF MEDICINE Department of Nephrology About Cleveland Clinic Florida Cleveland Clinic Florida s medical staff are dedicated physicians who have joined the clinic as salaried doctors to

More information

Disclosures. Acute Kidney Injury. Outline. Do electronic alerts improve the care of patients with AKI? 5/9/2015

Disclosures. Acute Kidney Injury. Outline. Do electronic alerts improve the care of patients with AKI? 5/9/2015 Disclosures Acute Kidney Injury Kathleen D. Liu, MD, PhD May 2015 Consultant: Achaogen, Chemocentryx, Durect, Z Pharma Clinical trials adjudication: Astute Funding: NIH Stockholder: Amgen Outline patients

More information

Clinical Performance Goals

Clinical Performance Goals Clinical Performance Goals 2012-2013 Clinical Performance Goals 2012-2013 Table of Contents Table of Contents... 1 Health Care Quality Improvement Program... 2 ESRD Quality Incentive Program (QIP)... 5

More information

Advancing the management of Chronic Kidney Disease. Employee Benefits Planning Association- December s Program 12/6/2017 1

Advancing the management of Chronic Kidney Disease. Employee Benefits Planning Association- December s Program 12/6/2017 1 Advancing the management of Chronic Kidney Disease. Employee Benefits Planning Association- December s Program 12/6/2017 1 Today s Topics Chronic Kidney Disease Causes & Financial Impact Managing comorbid

More information

Proposed Changes to the 2018 ESRD PPS a. Patient and Facility Payment Adjusters

Proposed Changes to the 2018 ESRD PPS a. Patient and Facility Payment Adjusters August 24, 2017 Seema Verma Administrator Centers for Medicare and Medicaid Services Room 314G Hubert H. Humphrey Building, 200 Independence Avenue, SW Washington, DC 20201 RE: CMS-1674-P: Medicare Program;

More information

Management of the Frail Older Patients: What Are the Outcomes

Management of the Frail Older Patients: What Are the Outcomes Management of the Frail Older Patients: What Are the Outcomes Professor Edwina Brown Imperial College Renal and Transplant Centre Hammersmith Hospital, London Increasing prevalence of old old on RRT RRT

More information

The vexing problem of suboptimal initiation of dialysis: Can we do better?

The vexing problem of suboptimal initiation of dialysis: Can we do better? Budapest Nephrology School August 30, 2010 The vexing problem of suboptimal initiation of dialysis: Can we do better? David C Mendelssohn Disclosures 2007 2010 Speaker Fees: Amgen, Ortho Biotech, Genzyme,

More information

Is a kidney transplant right for me?

Is a kidney transplant right for me? Is a kidney transplant right for me? Your guide to the transplant process www.esrdncc.org Contents Introduction 3 What is a Transplant Center? 4 What is the Waiting List? 5 What Happens After the Surgery?

More information

Pulmonary Rehabilitation

Pulmonary Rehabilitation Pulmonary Rehabilitation New Benefit The enactment of HR 6331, the Medicare Improvements for Patients and Providers Act of 2008, established a specific Medicare benefit for pulmonary rehabilitation. The

More information

National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC)

National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC) National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC) A service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) Kidney

More information

02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have?

02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have? HOME HEMODIALYSIS SYMPOSIUM ANNUAL DIALYSIS CONFERENCE 2018 HOW CAN WE FOSTER MORE PHYSICIAN CHAMPIONS? Joel D. Glickman, M.D. Director, Home Dialysis Programs Professor of Clinical Medicine University

More information

Potentially Preventable Hospitalizations

Potentially Preventable Hospitalizations Potentially Preventable Hospitalizations What does kidney disease have to do with it? Elaine Braslow, MEd September 29, 2015 About your kidneys What do the kidneys do? Prevent buildup of wastes and extra

More information

Hospice in ESRD: To Withdraw or Not to Withdraw

Hospice in ESRD: To Withdraw or Not to Withdraw Hospice in ESRD: To Withdraw or Not to Withdraw Access to Hospice for Patients with ESRD Rebecca J. Schmidt, DO, FACP October 2005 In which scenario may the hospice benefit be engaged? ESRD patient with

More information

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 TREAT THE KIDNEY TO SAVE THE HEART Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 1 ESRD Prevalent Rates in 1996 per million population December

More information

04 Chapter Four Treatment modalities. Experience does not err, it is only your judgement that errs in expecting from her what is not in her power.

04 Chapter Four Treatment modalities. Experience does not err, it is only your judgement that errs in expecting from her what is not in her power. Chapter Four Treatment modalities Experience does not err, it is only your judgement that errs in expecting from her what is not in her power. LEONARDO da Vinci Vol 2 esrd Ch pg 29 Contents 22 Incident

More information

Internal Medicine Dialysis Provider Perspective Joe Ghata

Internal Medicine Dialysis Provider Perspective Joe Ghata Internal Medicine Dialysis Provider Perspective Joe Ghata Disclaimers 1 Learning Objectives Transition vs Transfer Healthcare Utilization Among AYA with ESRD Home hemodialysis Modalities Undocumented AYA

More information

Who? Dialysis for Acute Renal Failure: Who, What, How, and When? Kathleen D. Liu, MD, PhD, MAS June 2011

Who? Dialysis for Acute Renal Failure: Who, What, How, and When? Kathleen D. Liu, MD, PhD, MAS June 2011 Dialysis for Acute Renal Failure: Who, What, How, and When? Kathleen D. Liu, MD, PhD, MAS June 2011 Dorre Nicholau MD PhD Clinical Professor Department of Anesthesia and Perioperative Care University of

More information

Strategies to assess and manage hypervolemia The invisible threat in dialysis

Strategies to assess and manage hypervolemia The invisible threat in dialysis Strategies to assess and manage hypervolemia The invisible threat in dialysis Rajiv Agarwal MD Professor of Medicine, Indiana University School of Medicine Volume excess is common and costly. Admission

More information

Section 3: Prevention and Treatment of AKI

Section 3: Prevention and Treatment of AKI http://www.kidney-international.org & 2012 KDIGO Summary of ommendation Statements Kidney International Supplements (2012) 2, 8 12; doi:10.1038/kisup.2012.7 Section 2: AKI Definition 2.1.1: AKI is defined

More information

Volume 1: CKD Analytical Methods

Volume 1: CKD Analytical Methods Volume 1: CKD Analytical Methods Contents CKD Analytical Methods... 1 Introduction...2 Data Sources...2 National Health and Nutrition Examination Survey...2 Behavioral Risk Factor Surveillance System...2

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Volume 2: ESRD Analytical Methods Contents Introduction...352 Data Sources...352 Renal Management Information System...353 CROWNWeb and Standard Information Management

More information

CROWNWeb, the ESRD QIP, and You Town Hall

CROWNWeb, the ESRD QIP, and You Town Hall CROWNWeb, the ESRD QIP, and You Town Hall Questions and Answers ESRD QIP: Accessing Your Facility s PY 2016 Reporting Documents Question When will the Performance Score Certificate (PSC) be available?

More information

Acute kidney injury definition, causes and pathophysiology. Financial Disclosure. Some History Trivia. Key Points. What is AKI

Acute kidney injury definition, causes and pathophysiology. Financial Disclosure. Some History Trivia. Key Points. What is AKI Acute kidney injury definition, causes and pathophysiology Financial Disclosure Current support: Center for Sepsis and Critical Illness Award P50 GM-111152 from the National Institute of General Medical

More information

Arkansas Health Care Payment Improvement Initiative Congestive Heart Failure Algorithm Summary

Arkansas Health Care Payment Improvement Initiative Congestive Heart Failure Algorithm Summary Arkansas Health Care Payment Improvement Initiative Congestive Heart Failure Algorithm Summary Congestive Heart Failure Algorithm Summary v1.2 (1/5) Triggers PAP assignment Exclusions Episode time window

More information

Utopia Health Career Center, LLC. Do not distribute without permission.

Utopia Health Career Center, LLC. Do not distribute without permission. Introduction What is dialysis and a brief history. What laws govern dialysis treatments. How to ensure high quality care for patients. How to behave in a professional way. How to become certified. We don

More information

Agroup of clinicians, researchers, ... REPORT... Chronic Kidney Disease: Stating the Managed Care Case for Early Treatment

Agroup of clinicians, researchers, ... REPORT... Chronic Kidney Disease: Stating the Managed Care Case for Early Treatment ... REPORT... Chronic Kidney Disease: Stating the Managed Care Case for Early Treatment Discussion and Consensus of Presentations of Economic Analyses, Managed Care Organization Case Studies, and Opportunities

More information

Merit-based Incentive Payment System (MIPS): Cost Measure Field Test Reports Fact Sheet

Merit-based Incentive Payment System (MIPS): Cost Measure Field Test Reports Fact Sheet Merit-based Incentive Payment System (MIPS): Cost Measure Field Test Reports Fact Sheet The Quality Payment Program The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) established the Quality

More information

Chapter 2 End-Stage Renal Disease: Scope and Trends

Chapter 2 End-Stage Renal Disease: Scope and Trends Chapter 2 End-Stage Renal Disease: Scope and Trends Chapter 2 End-Stage Renal Disease: Scope and Trends END-STAGE RENAL DISEASE DEFINED The primary functions of the kidney are to remove waste products

More information

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes

Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes Measure #403: Adult Kidney Disease: Referral to Hospice National Quality Strategy Domain: Patient and Caregiver-Centered Experience and Outcomes 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

The National Kidney Foundation (NKF) is pleased to submit testimony regarding the impact of

The National Kidney Foundation (NKF) is pleased to submit testimony regarding the impact of STATEMENT OF THE NATIONAL KIDNEY FOUNDATION 30 EAST 33 RD STREET NEW YORK, NY 10016 SUBMITTED TO THE HOUSE COMMITTEE ON APPROPRIATIONS; SUBCOMMITTEE ON LABOR, HHS, EDUCATION, AND RELATED AGENCIES IN SUPPORT

More information

Outpatient dialysis services

Outpatient dialysis services C H A P T E R6 Outpatient dialysis services R E C O M M E N D A T I O N 6 The Congress should update the outpatient dialysis payment rate by 1 percent for calendar year 2013. COMMISSIONER VOTES: YES 17

More information

2018 USRDS Annual Data Report: Executive Summary

2018 USRDS Annual Data Report: Executive Summary 2018 USRDS Annual Data Report: Executive Summary Introduction This year marks the publication of the 29th Annual Data Report (ADR) of the United States Renal Data System (USRDS). Broadly, the mission of

More information

Palliative Care Quality Improvement Program (QIP) Measurement Specifications

Palliative Care Quality Improvement Program (QIP) Measurement Specifications Palliative Care Quality Improvement Program (QIP) 2017-18 Measurement Specifications Developed by: QIP Team Contact: palliativeqip@partnershiphp.org Published on: October 6, 2017 Table of Contents Program

More information

Chapter 15 Section 1

Chapter 15 Section 1 Chapter 15 Section 1 Issue Date: November 6, 2007 Authority: 32 CFR 199.14(a)(3) and (a)(6)(ii) 1.0 APPLICABILITY This policy is mandatory for the reimbursement of services provided either by network or

More information

Case Review of Inpatient Rehabilitation Hospital Patients Not Suited for Intensive Therapy

Case Review of Inpatient Rehabilitation Hospital Patients Not Suited for Intensive Therapy U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES OFFICE OF INSPECTOR GENERAL Case Review of Inpatient Rehabilitation Hospital Patients Not Suited for Intensive Therapy OEI-06-16-00360 DECEMBER 2016 SUZANNE MURRIN

More information

Medicare Severity-adjusted Diagnosis Related Groups (MS-DRGs) Coding Adjustment

Medicare Severity-adjusted Diagnosis Related Groups (MS-DRGs) Coding Adjustment American Hospital association December 2012 TrendWatch Are Medicare Patients Getting Sicker? Today, Medicare covers more than 48 million people, and that number is growing rapidly baby boomers are reaching

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions

More information

September 10, Dear Administrator Verma:

September 10, Dear Administrator Verma: September 10, 2018 Ms. Seema Verma Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS-1674-P P.O. Box 8010 Baltimore, Maryland 21244-8010 Re:

More information

Improved IPGM: Demonstrating the Value to both Patients and Hospitals

Improved IPGM: Demonstrating the Value to both Patients and Hospitals Improved IPGM: Demonstrating the Value to both Patients and Hospitals Osama Hamdy, MD, PhD, FACE Medical Director, Inpatient Diabetes Program Joslin Diabetes Center Harvard Medical School, Boston, MA Cost

More information

Difference in practical dialysis therapy between East Asia and US/EU

Difference in practical dialysis therapy between East Asia and US/EU Difference in practical dialysis therapy between East Asia and US/EU Jer-Ming Chang. M.D., Ph.D. 1 Professor, Attending physician, Kaohsiung Medical University Hospital; 2 Secretary General, Taiwan Society

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 8: Transition of Care in CKD Almost 30% of all 52,172 veterans who transitioned to ESRD across the nation over a 4-year period (10/2007-9/2011) received anti-depressant

More information

Efficiency Methodology

Efficiency Methodology Efficiency Methodology David C. Schutt, MD Bob Kelley Thomson Healthcare October 2007 Overview Definition Clinical Grouping Methods Implementation Considerations Reporting to Physician Organizations Example

More information

Objectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring

Objectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School

More information